Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-01 Sale |
2020-12-03 5:17 pm |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
137,061 | $17.53 | $2,402,227 | 68,241 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 4:09 pm |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
772 | $14.92 | $11,518 | 4,523 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 6:00 pm |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
39,271 | $16.86 | $661,969 | 144,678 (Direct) |
View |
| 2020-09-08 Sale |
2020-09-10 08:49 am |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
10,054 | $14.98 | $150,609 | 4,649 (Direct) |
View |
| 2020-05-07 Sale |
2020-05-11 4:25 pm |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
9,660 | $19.73 | $190,627 | 14,703 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-10-28 Option Award |
2021-10-29 7:23 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Primiano Christopher Brett Chief Business Officer |
46,250 | $0 | 46,250 (Direct) |
View |
Ownership |
2021-10-28 8:18 pm |
N/A 2031-09-22 |
Aura Biosciences Inc. | AURA | Primiano Christopher Brett Chief Business Officer |
0 | $0 | 124,087 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 5:17 pm |
N/A 2028-01-23 |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
137,061 | $0 | 68,241 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 5:17 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
78,124 | $10.45 | 68,241 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 5:17 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
58,937 | $10.39 | 68,241 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-14 6:00 pm |
N/A 2029-02-14 |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
39,271 | $0 | 144,678 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-14 6:00 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
38,550 | $9.21 | 144,678 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-14 6:00 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
721 | $10.39 | 144,678 (Direct) |
View |
| 2020-09-08 Exercise |
2020-09-10 08:49 am |
N/A 2026-01-14 |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
10,054 | $0 | 4,649 (Direct) |
View |
| 2020-09-08 Exercise |
2020-09-10 08:49 am |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
10,054 | $6.54 | 4,649 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 4:25 pm |
N/A 2026-01-14 |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
2,946 | $0 | 14,703 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 4:25 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
2,946 | $6.54 | 14,703 (Direct) |
View |